Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

76 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Research priorities for neglected infectious diseases in Latin America and the Caribbean region.
Dujardin JC, Herrera S, do Rosario V, Arevalo J, Boelaert M, Carrasco HJ, Correa-Oliveira R, Garcia L, Gotuzzo E, Gyorkos TW, Kalergis AM, Kouri G, Larraga V, Lutumba P, Macias Garcia MA, Manrique-Saide PC, Modabber F, Nieto A, Pluschke G, Robello C, Rojas de Arias A, Rumbo M, Santos Preciado JI, Sundar S, Torres J, Torrico F, Van der Stuyft P, Victoir K, Olesen OF. Dujardin JC, et al. Among authors: modabber f. PLoS Negl Trop Dis. 2010 Oct 26;4(10):e780. doi: 10.1371/journal.pntd.0000780. PLoS Negl Trop Dis. 2010. PMID: 21049009 Free PMC article. Review. No abstract available.
CpG ODN D35 improves the response to abbreviated low-dose pentavalent antimonial treatment in non-human primate model of cutaneous leishmaniasis.
Thacker SG, McWilliams IL, Bonnet B, Halie L, Beaucage S, Rachuri S, Dey R, Duncan R, Modabber F, Robinson S, Bilbe G, Arana B, Verthelyi D. Thacker SG, et al. Among authors: modabber f. PLoS Negl Trop Dis. 2020 Feb 28;14(2):e0008050. doi: 10.1371/journal.pntd.0008050. eCollection 2020 Feb. PLoS Negl Trop Dis. 2020. PMID: 32109251 Free PMC article.
Comparison of short-course multidrug treatment with standard therapy for visceral leishmaniasis in India: an open-label, non-inferiority, randomised controlled trial.
Sundar S, Sinha PK, Rai M, Verma DK, Nawin K, Alam S, Chakravarty J, Vaillant M, Verma N, Pandey K, Kumari P, Lal CS, Arora R, Sharma B, Ellis S, Strub-Wourgaft N, Balasegaram M, Olliaro P, Das P, Modabber F. Sundar S, et al. Among authors: modabber f. Lancet. 2011 Feb 5;377(9764):477-86. doi: 10.1016/S0140-6736(10)62050-8. Epub 2011 Jan 20. Lancet. 2011. PMID: 21255828 Clinical Trial.
First generation leishmaniasis vaccines: a review of field efficacy trials.
Noazin S, Modabber F, Khamesipour A, Smith PG, Moulton LH, Nasseri K, Sharifi I, Khalil EA, Bernal ID, Antunes CM, Kieny MP, Tanner M. Noazin S, et al. Among authors: modabber f. Vaccine. 2008 Dec 9;26(52):6759-67. doi: 10.1016/j.vaccine.2008.09.085. Epub 2008 Oct 23. Vaccine. 2008. PMID: 18950671 Review.
Vaccines against leishmaniasis.
Modabber F. Modabber F. Ann Trop Med Parasitol. 1995 Dec;89 Suppl 1:83-8. doi: 10.1080/00034983.1995.11813017. Ann Trop Med Parasitol. 1995. PMID: 8745930 Review.
76 results